Compass Therapeutics Inc.

CMPX | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.29

-$0.53 (-29.12%)

Sep 22, 2026, 1:47 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-66.49M	-49.38M	-42.49M	-39.23M	-82.18M	-29.5M
Depreciation & Amortization	-1.4M	1.75M	1.89M	1.9M	1.62M	2.4M
Stock-Based Compensation	8.37M	8.56M	6.12M	5.33M	4.03M	4.02M
Other Working Capital	9.84M	-2.3M	-3.62M	-3.78M	6.44M	-4.03M
Other Non-Cash Items	1.2M	-1.65M	-3.23M	-871K	50.62M	-960K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	837K
Change in Working Capital	9.18M	-4.14M	-2.91M	-1.26M	6.25M	-3.6M
Operating Cash Flow	-49.14M	-44.86M	-40.62M	-34.13M	-19.67M	-26.8M
Capital Expenditures	-25K	-44K	-30K	-212K	-1.57M	-106K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	144K
Purchase of Investments	-194.56M	-88.16M	-155.42M	-200.12M	n/a	n/a
Sales Maturities Of Investments	101.28M	134.97M	182.41M	48.96M	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	176K	-202K	144
Investing Cash Flow	-93.31M	46.77M	26.97M	-151.2M	-1.77M	38K
Debt Repayment	n/a	n/a	n/a	n/a	-9.38M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-1.03M	-775K	-159K	75.76M	-281K	-6.32M
Financial Cash Flow	129.61M	17.34M	2.94M	75.76M	118.61M	48.54M
Net Cash Flow	-12.84M	19.26M	-10.72M	-109.57M	97.18M	21.77M
Free Cash Flow	-49.17M	-44.9M	-40.65M	-34.34M	-21.23M	-26.91M
Adj. Free Cash Flow	-57.54M	-53.46M	-46.77M	-39.67M	-25.26M	-30.93M
Maintenance CapEx	-25K	n/a	-30K	-212K	-1.57M	-106K
Growth CapEx	n/a	-44K	n/a	n/a	n/a	n/a
Owner Earnings	-49.17M	-44.86M	-40.65M	-34.34M	-21.23M	-26.91M